Profile | GDS4284 / 1552610_a_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4611.57 | 92 |
GSM687648 | Patient 402 control | 3102.92 | 89 |
GSM687653 | Patient 403 control | 4452.78 | 92 |
GSM687658 | Patient 404 control | 3010.86 | 89 |
GSM687663 | Patient 411 control | 4174.57 | 92 |
GSM687668 | Patient 422 control | 4930.52 | 93 |
GSM687673 | Patient 424 control | 4807.25 | 93 |
GSM687678 | Patient 425 control | 3775.62 | 91 |
GSM687683 | Patient 427 control | 2926.05 | 88 |
GSM687688 | Patient 428 control | 3640.25 | 91 |
GSM687695 | Patient 441 control | 4588.6 | 93 |
GSM687699 | Patient 443 control | 3445.42 | 90 |
GSM687704 | Patient 444 control | 3293.3 | 90 |
GSM687707 | Patient 448 control | 5693.45 | 94 |
GSM687712 | Patient 449 control | 3366.93 | 90 |
GSM687719 | Patient 450 control | 3083.6 | 89 |
GSM687724 | Patient 451 control | 4664.35 | 93 |
GSM687728 | Patient 452 control | 3597.24 | 91 |
GSM687646 | Patient 401 treated 24h | 3380.8 | 90 |
GSM687649 | Patient 402 treated 24h | 3374.62 | 90 |
GSM687665 | Patient 411 treated 24h | 3676.71 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 3490.28 | 90 |
GSM687667 | Patient 411 treated 4 weeks | 5018.71 | 93 |
GSM687670 | Patient 422 treated 24h | 4673.89 | 93 |
GSM687671 | Patient 422 treated 4 weeks | 7455.57 | 96 |
GSM687654 | Patient 403 treated 24h | 3965.96 | 91 |
GSM687675 | Patient 424 treated 24h | 5416.9 | 94 |
GSM687685 | Patient 427 treated 24h | 3343.42 | 90 |
GSM687656 | Patient 403 treated 4 weeks | 6860.22 | 95 |
GSM687677 | Patient 424 treated 4 weeks | 3717.34 | 91 |
GSM687687 | Patient 427 treated 4 weeks | 6141.43 | 95 |
GSM687692 | Patient 428 treated 4h | 3286.43 | 90 |
GSM687716 | Patient 449 treated 4h | 3528.95 | 90 |
GSM687722 | Patient 450 treated 4h | 1901.75 | 83 |
GSM687680 | Patient 425 treated 24h | 2945.9 | 88 |
GSM687690 | Patient 428 treated 24h | 3024.64 | 89 |
GSM687700 | Patient 443 treated 24h | 2593.39 | 88 |
GSM687705 | Patient 444 treated 24h | 3494.88 | 90 |
GSM687714 | Patient 449 treated 24h | 4085.68 | 92 |
GSM687721 | Patient 450 treated 24h | 3368.6 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 1684.95 | 82 |
GSM687694 | Patient 428 treated 4 weeks | 3370.76 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 3818.52 | 91 |
GSM687718 | Patient 449 treated 4 weeks | 2829.13 | 88 |
GSM687723 | Patient 450 treated 4 weeks | 3611.28 | 91 |
GSM687661 | Patient 404 treated 4h | 3134.74 | 89 |
GSM687710 | Patient 448 treated 4h | 7053.47 | 95 |
GSM687726 | Patient 451 treated 4h | 4086.46 | 92 |
GSM687730 | Patient 452 treated 4h | 248.086 | 37 |
GSM687660 | Patient 404 treated 24h | 1821.54 | 84 |
GSM687697 | Patient 441 treated 24h | 3960.32 | 92 |
GSM687709 | Patient 448 treated 24h | 6011.06 | 95 |
GSM687725 | Patient 451 treated 24h | 4107.15 | 92 |
GSM687729 | Patient 452 treated 24h | 4777.84 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 4681.73 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 4819.33 | 93 |